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CASE REPORT 
ARDS and systemic sepsis from Actinomycosis  
related IUCD infection 
Kimberley Grech, John Mamo
Six weeks following a reinsertion of a levonorgestrel intrauterine 
contraceptive device (IUCD), this 43 year old lady was admitted with 
severe abdominal pain. Radiological investigations indicated fluid 
collection in the rectovaginal area. The differential diagnosis 
included pelvic inflammatory disease with a possible pyosalpinx.  The 
condition of the patient deteriorated further developing bilateral 
pleural effusions and pulmonary edema despite antibiotics.  Patient 
started improving after CT guided aspiration of the pelvic abscess. 
Further management with antibiotics was administered after blood 
cultures showed an Actinomycosis infection. This patient presenting 
with a non-pulmonary cause of sepsis deteriorated rapidly and 
developed Adult Respiratory Distress syndrome. Although 
Actinomycosis is detected incidentally on cervical cytology in 
asymptomatic patients with an intrauterine device, it may present 
with lethargy, pyrexia and rigors. Prior to removal/re-insertion of an 
IUCD, cervical smears specifically for actinomyces should be done and 
patients should be treated with antibiotics if positive. The IUCD 
should then be introduced 6 weeks later. IUCD’s should not be left in 
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INTRODUCTION 
Actinomycosis in humans is a disease caused 
either by Actinomyces israelii, A gerencseriae 
and Propionibacterium propionicus. 
Actinomyces Israeli (principal pathogens) are 
Gram-positive rods. They are mostly 
commensals, living in the vagina, mouth and 
colon. A break in the mucosa for example 
during the insertion of Intrauterine 
Contraceptive Device (IUCD) will cause 
invasion of tissues by this bacterium.  
With reference to IUCD related infections, two 
known mechanisms have been explained by 
which actinomyces israelii may lead to Pelvic 
Inflammatory Disease (PID). One mechanism 
describes how the string of the IUCD acts as a 
vehicle for ascent of the microbe from the 
vagina into the uterine fundus.1  
The second mechanism describes how an IUCD 
which would have been kept in situ beyond its 
expected date of change/removal, undergoes 
calcium encrustation and disintegration. These 
calcium encrusted plastic fragments migrate 
through the cervical canal into the uterus 
providing an ideal surface for colonization and 
spread of the organism.1 However this is 
mostly related to the Lippes loop IUCD which 
were left in situ for years on end as they did not 
expire.  
We would suggest a third mechanism by which 
an infection is introduced into the uterine 
cavity. When removing the IUCD on expiry, you 
are also removing the “protective” mucous 
plug which would have been produced by the 
progestin releasing device. Hence if there is 
actinomyces present within the cervical canal, 
it can be reintroduced into the cavity upon re-
insertion. This argument re-enforces the need 
to carry out smear tests prior to re-insertion of 
IUCD.   
Actinomycosis detected in cervical smears may 
be present in symptom free patients. However 
early symptoms include low grade fever, chills 
and rigors. Eventually, late presentations 
include pelvic pain, foul smelling discharge 
leading to hospital admission with abscess 
formation.1 Actinomycosis infection is 
sensitive to Penicillin. 
THE CASE 
A 43 year old athletic lady with a known case of 
endometriosis was admitted with sudden 
onset of right iliac fossa pain (RIF).  A change of 
IUCD had been done 6 weeks before 
admission.  Upon examination, tenderness 
with guarding was present in the RIF. A 
pregnancy test was negative and a chest X-ray 
and abdominal X-ray reported no 
abnormalities beside an IUCD in situ. 
Eventually a computed tomography scan (CT 
scan) was done which noted a fluid collection 
of 55mm in diameter between the uterus and 
rectum. 
A transvaginal gynaecological ultrasound was 
done which reported an IUCD in situ, a cystic 
ovary in the right adnexae of mixed 
echogenicity and a small follicle in the left 
ovary. The pouch of Douglas was clear.  
The patient was given analgesia and started on 
Piperacillin/Tazobactam and Metronidazole 
intravenously (IV). During her admission she 
developed bilateral lower limb pitting edema 
up to thighs and shortness of breath (SOB).  
Hypoalbuminaemia was also reported on 
blood tests. Eventually the SOB worsened, 
developing bilateral pleural effusions and 
bilateral lower lobe lung collapse. A Brain 
Natriuretic Peptide (BNP) was requested as 
the patient presented with a clinical picture of 
heart failure. BNP was reported to be high. An 
echocardiogram confirmed normal left 
ventricular dimensions, normal wall motions, 
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left ventricular ejection fraction >60%, normal: 
left atrium, right atrium and right ventricle 
excluding heart failure. Bumetanide and 
Albumin supplements were administered to 
reduce the extravasation of fluid secondary to 
sepsis. 
The main diagnosis established was systemic 
sepsis due to PID, with development of Acute 
Respiratory Distress Syndrome (ARDS) and 
lower limb edema. The possible cause of PID 
was a pyosalpinx following IUCD insertion. The 
IUCD was removed. 
A CT guided drainage of abscess was done. 
Eventually the patient continued to spike fever 
and antibiotics were switched to Teicoplanin 
and Meropenam IV. Blood cultures were 
obtained which cultivated Actinomyces.  
Eventually the patient still continued to 
experience fluctuating fevers in view of a 
recollection of the abscess and antibiotics 
were switched to Benzylpenicillin and 
Clindamycin IV. 
DISCUSSION 
The relationship between cervical smears and 
its association with PID 
The presence of actinomyces-like organisms 
on cervical smears is uncommon (only 7% of 
smears).2 Many studies reported that 
incidence of Actinomyces-like organisms in 
IUCD’s is higher. Positive smears are not 
diagnostic, nor a predictor of pelvic 
actinomycosis. Therefore most patients are 
treated conservatively unless symptomatic.  
According to Merki-Feld GS et al. 
levonorgestrel-releasing IUCD users have a 
lower incidence of actinomyces-like organisms 
compared to copper-IUCD users. Women who 
have an IUCD insitu are more likely to develop 
bacterial vaginosis compared to the general 
public. This makes an environment favourable 
to anaerobes within the vagina facilitating 
actinomyces growth. 3-4 
Removing IUCD’s once actinomycosis is 
detected still remains controversial. Treating 
conservatively usually results in negative 
cervical cytology after 4-6 weeks. Merki-Feld 
GS et al suggested IUCD removal should be 
done within a period of 3-5 days after starting 
treatment rather than immediately upon 
detection. Reinsertion should be done 4-6 
weeks later.3 
Studies by Chatwani. A and Amin-Hanjani. S 
conducted in Philadelphia showed that 
negative follow up smears, had a success rate 
of 100% when the option of IUCD removal 
combined with antibiotics was considered, 
97.4% for IUCD removal alone, and 36.8% for 
antibiotics therapy alone. Hence it was 
concluded that the best way to manage 
actinomycoses is by removal of the IUCD with 
or without antibiotics. Patients who had 
multiple antibiotics including penicillin and 
tetracyclins had a better outcome compared 
to those patients who were on monotherapy.5  
Actinomycosis and PID 
Patients’ with actinomycotic IUCD colonization 
have a greater risk of developing 
actinomycotic tubo-ovarian and subphrenic 
abscesses then those women with no IUCD 
colonization.6 A period of at least 4-6 weeks of 
therapy is usually recommended. Most 
patients with pelvic masses underwent 
hysterectomy and bilateral salpingo-
oophorectomy in addition to penicillin and 
IUCD removal; a few were successfully treated 
with drainage of an intra-abdominal abscess 
just like in this case. 
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Fluid extravasation in systemic sepsis 
leading to ARDS 
In this case the initial signs of bilateral lower 
edema and increased SOB in such a young, 
healthy haemodynamically stable patient were 
surprising. Considering the patient’s past 
medical history of intense physical body 
training; cardiomyopathy induced heart failure 
was being considered as a differential. A BNP 
of 457 (high) reinforced the decision to do an 
echo which excluded such pathology. Other 
causes of bilateral lower limb edema such as 
renal failure and liver failure were excluded 
through normal blood work up.  
Upon reviewing the case; the development of 
pleural effusions, persistent lower limb 
edema, and hypoalbuminaemia made the final 
diagnosis of fluid extravasation and ARDS 
secondary to sepsis more likely. In studies 
done by Nakamura T et al. BNP levels were 
positively correlated in septic patients having 
high CRP levels without echocardiographic 
evidence of systolic dysfunction or volume 
overload.7  
Furthermore, a positive correlation was found 
between a high BNP in septic shock patients 
and Sequential Organ Failure Assessment 
scores and prognosticated survival. Hence one 
can argue that BNP can be used as an 
independent prognostic marker in severe 
sepsis, being higher in non-survivors than 
survivors up to 72 hours post admission.8-9 
Acute respiratory distress syndrome is a 
serious complication of severe sepsis, 
increasing mortality rates.10 Underlying 
mechanisms are characterized by 
inflammation and endothelial 
dysfunction. Dysregulation of angiopoietin 
and Von Willebrand factor in endothelial injury 
are common findings in indirect causes of 
ARDS (non-pulmonary causes).11 6-7% of adult 
patients with sepsis in Western countries 
eventually develop ARDS. Once sepsis sets in, 
progression to ARDS is rapid. Hence 
identifying and treating sepsis early will 
reduce the need for patients to receive 
mechanical ventilation.12 Main treatment of 
ARDS is to maintain adequate tissue perfusion 
and avoid hypoxia.  
CONCLUSION 
The overall learning points of this case 
including: 1. IUCD’s should be removed 
immediately upon expiring; 2. Cervical 
cytology smears with specific request to 
screen for Actinomyces should be done prior to 
removal and/or re-insertion of IUCD’s.  3. 
Removal of IUCD and treatment with 
antibiotics is the best option for Actinomyces 
positive smears. 4. ARDS secondary to 
systemic sepsis is an indicator of poor 
prognosis hence immediate treatment is 
recommended, BNP can be used as an 
independent prognostic marker in severe 
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